AKBA - Akebia Ther - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

AKBA is currently covered by 5 analysts with an average price target of $6.28. This is a potential upside of $4.89 (351.8%) from yesterday's end of day stock price of $1.39.

Akebia Ther's activity chart (see below) currently has 44 price targets and 55 ratings on display. The stock rating distribution of AKBA is 66.67% HOLD and 33.33% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43% with an average time for these price targets to be met of 192.73 days.

Highest price target for AKBA is $5, Lowest price target is $4, average price target is $6.28.

Most recent stock forecast was given by ED ARCE from HCWAINWRIGHT on 17-Nov-2023. First documented stock forecast 14-May-2015.

Currently out of the existing stock ratings of AKBA, 12 are a HOLD (66.67%), 6 are a BUY (33.33%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$3.61 (259.71%)

3.75

3 months 7 days ago

4/15 (26.67%)

$4 (400.00%)

147

Buy

4

$2.61 (187.77%)

8

8 months 24 days ago

1/11 (9.09%)

$2.96 (284.62%)

4

Buy

1

$-0.39 (-28.06%)

8

1 years 10 months 23 days ago

1/2 (50%)

$0.33 (49.25%)

311

Hold

2

$0.61 (43.88%)

6

1 years 10 months 24 days ago

2/9 (22.22%)

$1.28 (177.78%)

340

Buy

6

1 years 10 months 24 days ago

0/3 (0%)

$3.28 (120.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AKBA (Akebia Ther) average time for price targets to be met?

On average it took 192.73 days on average for the stock forecasts to be realized with a an average price target met ratio 43

Which analyst has the current highest performing score on AKBA (Akebia Ther) with a proven track record?

DIFEI YANG

Which analyst has the most public recommendations on AKBA (Akebia Ther)?

Difei Yang works at MIZUHO and has 22 price targets and 17 ratings on AKBA

Which analyst is the currently most bullish on AKBA (Akebia Ther)?

Jonathan Aschoff with highest potential upside - $24.86

Which analyst is the currently most reserved on AKBA (Akebia Ther)?

Alethia Young with lowest potential downside - -$0.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?